These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Prophylactic use of deoxyspergualin in living related renal transplantation. Okazaki H; Sato T; Jimbo M; Senga S; Amada N; Oguma S Transplant Proc; 1991 Feb; 23(1 Pt 2):1094-5. PubMed ID: 1989157 [No Abstract] [Full Text] [Related]
31. [Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - An update of existing recommendations]. Arns W; Budde K; Eitner F; Gwinner W; Hugo C; Pressmar K; Weimann A; Witzke O Dtsch Med Wochenschr; 2011 Dec; 136(49):2554-9. PubMed ID: 22131077 [No Abstract] [Full Text] [Related]
32. Gusperimus: immunological mechanism and clinical applications. Perenyei M; Jayne DR; Floßmann O Rheumatology (Oxford); 2014 Oct; 53(10):1732-41. PubMed ID: 24501242 [TBL] [Abstract][Full Text] [Related]
33. [Intermittent administration of 15-deoxyspergualin for acute on chronic rejection after renal transplantation]. Kawamoto S; Kanematsu E; Kanimoto Y; Kawada Y Hinyokika Kiyo; 1996 Dec; 42(12):931-5. PubMed ID: 9013227 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of rejection with deoxyspergualin after renal transplantation]. Shinohara Y; Imanishi M; Nishioka T; Uemura T; Kanda H; Matsuura T; Akiyama T; Kurita T Nihon Hinyokika Gakkai Zasshi; 1992 Feb; 83(2):236-42. PubMed ID: 1556844 [TBL] [Abstract][Full Text] [Related]
35. Immunosuppressive effect of deoxyspergualin on acute renal allograft rejection in dogs. Fukao K; Otsuka M; Iwasaki H; Yuzawa K; Iwasaki Y Transplant Proc; 1989 Feb; 21(1 Pt 1):1090-3. PubMed ID: 2650068 [No Abstract] [Full Text] [Related]
36. Deoxyspergualin: clinical trials in renal graft rejection. Japan Collaborative Transplant Study of Deoxyspergualin. Amemiya H Ann N Y Acad Sci; 1993 Jun; 685():196-201. PubMed ID: 8363223 [TBL] [Abstract][Full Text] [Related]
37. Successful treatment of accelerated vascular rejection in a highly immunised renal transplant recipient with immunoadsorption and 15-deoxyspergualin. Braun N; Wernet D; Schnaidt M; Bevan DJ; Viebahn R; Risler T Transpl Int; 2004 Aug; 17(7):384-6. PubMed ID: 15278264 [No Abstract] [Full Text] [Related]
38. Long-term outcome of cadaveric kidney grafts with triple drug therapy. Amemiya H; Suzuki S; Hayashi R; Nakatani T Transplant Proc; 1994 Aug; 26(4):2097-8. PubMed ID: 8066683 [No Abstract] [Full Text] [Related]
39. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation. Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233 [No Abstract] [Full Text] [Related]
40. FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis. Kliem V; Eberhard OK; Oldhafer K; Schlitt HJ; Behrend M; Schaumann D; Pichlmayr R; Koch KM; Brunkhorst R Transplant Proc; 1996 Dec; 28(6):3166-8. PubMed ID: 8962227 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]